Relay Therapeutics (RLAY) Return on Sales (2021 - 2026)

Relay Therapeutics (RLAY) reported Return on Sales of 0.24% for Q1 2026, down 14.0% year-over-year from 0.28% in Q1 2025, and down 211.16% on a QoQ basis from 0.08% in Q4 2025.

Relay Therapeutics (RLAY) has 6 years of Return on Sales data on file, last reported at 0.24% in Q1 2026.

  • Quarterly Return on Sales fell 14.0% year-over-year to 0.24% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.25% (up 18.0% YoY) and the FY2025 annual result came in at 0.18%, up 16.0% from the prior year.
  • Return on Sales declined to 0.24% in Q1 2026 per RLAY's latest filing, from 0.08% in the prior quarter.
  • Across five years, Return on Sales topped out at 834.96% in Q4 2023 and bottomed at 8.28% in Q2 2023.
  • The 5-year median for Return on Sales is 0.35% (2024), against an average of 47.71%.
  • The widest annual swing landed in 2023, when Return on Sales jumped 83763 bps; it then plunged 83530 bps in 2024.
  • Tracing RLAY's Return on Sales over 5 years: stood at 2.67% in 2022, then soared by 31405 bps to 834.96% in 2023, then slumped by 100 bps to 0.34% in 2024, then jumped by 77 bps to 0.08% in 2025, then sank by 211 bps to 0.24% in 2026.
  • Per Business Quant, the three latest RLAY Return on Sales figures stand at 0.24% (Q1 2026), 0.08% (Q4 2025), and 0.36% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 0.00%
7 Evaxion A 64.16 Bn 64.14 Bn - 0.00%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.00%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 0.00%
10 Relay Therapeutics 2.53 Bn 2.53 Bn - -0.24%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.24%
Dec 31, 2025 -0.08%
Sep 30, 2025 -0.36%
Jun 30, 2025 -1.03%
Mar 31, 2025 -0.10%
Dec 31, 2024 -0.34%
Sep 30, 2024 -0.35%
Jun 30, 2024 -0.09%
Mar 31, 2024 -0.08%
Dec 31, 2023 834.96%
Sep 30, 2023 -0.03%
Jun 30, 2023 -8.28%
Mar 31, 2023 -4.17%
Dec 31, 2022 -2.67%
Sep 30, 2022 -2.45%
Jun 30, 2022 -2.10%
Mar 31, 2022 -1.48%
Dec 31, 2021 -1.19%
Sep 30, 2021 -0.91%
Jun 30, 2021 -2.29%
Mar 31, 2021 -0.44%